The prevalence of gestational diabetes mellitus (GDM) and pregestational diabetes mellitus (DM) has been estimated to be up to 9.2 and 1% in the United States, respectively, and has been increasing.
The prevalence of gestational diabetes mellitus (GDM) and pregestational diabetes mellitus (DM) has been estimated to be up to 9.2 and 1% in the United States, respectively, and has been increasing. [1] [2] [3] GDM and pregestational DM have been studied as a risk factor for neonatal respiratory morbidity.
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Fetal hyperinsulinemia has been suggested to be associated with delayed pulmonary maturation. 9 Pregnancies complicated by GDM and pregestational DM are associated with higher risk of preterm delivery 10 and cesarean delivery, 4, 6 both of which are also risk factors for neonatal respiratory Keywords ► gestational diabetes ► neonatal respiratory morbidity ► pregestational diabetes ► propensity score
Abstract
Objective To examine the risk of neonatal respiratory morbidity associated with gestational and pregestational diabetes, accounting for the prematurity-associated risk using a propensity score analysis. Study design In a retrospective study including 222,978 singleton pregnancies, delivering at 24 0/7 to 41 6/7 weeks (2002-2008), we calculated a probability to deliver at term (!37 weeks of gestation). Outcomes were stratified by the probability to deliver at term (>0.8 and 0.8). Adjusted odds ratios (aORs) with 95% confidence intervals (95% CIs) were calculated.
Results Gestational and pregestational diabetes complicated 5.1 and 1.5% of pregnancies, respectively, and were associated with increased risks of neonatal respiratory morbidity compared with women without diabetes regardless of probability to deliver at term. However, these risks tended to be higher with a higher probability to deliver at term: respiratory distress syndrome (aOR: 1.5; 95% CI: 1.3-1.7 and aOR: 3.1; 95% CI: 2.6-3.7); transient tachypnea of newborn (aOR: 1.5; 95% CI: 1.3-1.6 and aOR: 2.2; 95% CI: 1.9-2.6); and apnea (aOR: 1.5; 95% CI: 1.2-1.7 and aOR: 3.2; 95% CI: 2.6-3.9, for gestational and pregestational at term, respectively).
Conclusion Diabetes was associated with increased risk of neonatal respiratory morbidity beyond what can be attributed to prematurity. Neonatal respiratory morbidities were increased with pregestational diabetes compared with gestational diabetes.
morbidity. 11, 12 Prior studies suggested that the risk of neonatal respiratory morbidity may differ by GDM compared with pregestational DM, but data are limited by small numbers, 4, 5, 13 and heterogeneous groups (singletons and multiple pregnancies, 4 term and preterm 5, 13 ). As GDM typically develops later in gestation, around 24 to 28 weeks, 14 fetuses are exposed to the risk of hyperinsulinemia for a shorter duration compared with fetuses of women with pregestational DM. However, fetal lung maturation occurs later in pregnancy; so, it is unclear whether neonatal respiratory morbidity would differ by the timing of DM. When trying to understand the contribution of GDM and pregestational DM to neonatal respiratory morbidity, it is important to distinguish morbidity associated with diabetes from that associated with prematurity. The primary aim of this study was to explore the risks of neonatal respiratory morbidity associated with GDM and pregestational DM while considering the propensity of prematurity in a large, contemporary U.S. obstetric population.
Methods
This was a secondary analysis of the Consortium Data were abstracted from the electronic medical record and mapped to predefined codes at the data coordinating center. Neonatal intensive care unit (NICU) charts were linked to the newborn records. International Classification of Diseases-9 (ICD-9) codes were also obtained. Data validation was conducted for four diagnoses: cesarean delivery for non-reassuring fetal heart rate tracing, asphyxia, NICU admission due to a respiratory diagnosis, and shoulder dystocia. Variables were highly concordant with the chart review (>95% for 16 out of 20 variables and !91.9% for all).
15
Validation of the electronic medical record was specifically performed for all neonates who were delivered at 34 0/7 weeks of gestation or later requiring oxygen or ventilation in the delivery room and subsequent NICU admission for respiratory support, and concordance was 97.3 to 99.7% with the medical charts. We limited the current analysis to singleton gestations delivering between 24 0/7 and 41 6/7 weeks of gestation (n ¼ 222,978). GDM and pregestational DM diagnoses were derived from the medical records and supplemented by ICD-9 codes. Our main interest was to investigate the risk of neonatal morbidity associated with the underlying pathology from GDM and pregestational DM independent of the neonatal physiologic immaturity associated with premature delivery. 12 A traditional analysis that adjusts for gestational age at delivery has been noted to induce bias in instances where the preterm delivery itself is an intermediate along the causal pathway in the presence of unmeasured confounders. 16, 17 Of note, stratification by gestational age at delivery causes the same bias as adjusting. One solution is to stratify women based on their probability for preterm or term delivery instead of whether they actually delivered preterm or term. To understand the neonatal respiratory morbidity associated with GDM and pregestational DM independent of prematurity, we calculated a probability to deliver at term (!37 weeks of gestation) using the following variables: maternal age, body mass index (BMI, kg/m 2 ) at delivery, race, insurance, parity, marital status, smoking, precursor for delivery (spontaneous labor, rupture of membranes, indicated [including all possible indications except GDM or pregestational DM], elective, no recorded indication), cervical status at admission (effacement, dilation, station), induction, whether they had a trial of labor, age of the delivering physician, type of hospital, and site. This analysis can develop groups that differ according to the exposure interest (GDM and pregestational DM), but have similar baseline characteristics. 18 The estimate captured the overall effect of diabetes on neonatal respiratory disease, for those at high risk for preterm or term delivery, and can be interpreted as the risk of neonatal respiratory disease attributable to the underlying diabetes. We defined high probability of delivery at term as probability >0.8 and low probability of delivery at term as probability 0.8 (i.e., preterm delivery). The probability of 0.8 was chosen as the cutoff point to best approximate the proportion of preterm deliveries in the general population: 12.2% of pregnancies had a low probability of delivery at term with this cutoff point, which was similar to the preterm delivery rate of 12.7% in 2007, the previous year of the CSL study.
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We examined pregnancy characteristics and compared within non-DM, GDM, and pregestational DM. Pregnancy characteristics included maternal age, BMI kg/m 2 at delivery, birth weight, gestational age, race/ethnicity, marital status, smoking during pregnancy, alcohol use during pregnancy, parity, health insurance, chronic hypertension, pregnancyassociated hypertension (gestational hypertension, preeclampsia, superimposed preeclampsia, and HELLP [hemolysis, elevated liver enzyme, low platelet] syndrome), cesarean delivery, and antenatal corticosteroid administration. Neonatal morbidities were examined and compared within non-DM, GDM, and pregestational DM after stratifying by probability of delivery at term. Neonatal morbidities include NICU admission and neonatal respiratory morbidity (respiratory distress syndrome [RDS] , transient tachypnea of newborn [TTN] , pneumonia, apnea, and mechanical ventilation).
In the CSL, detailed information on neonatal respiratory support and morbidities was obtained from chart review for all neonates who were delivered at 34 0/7 weeks of gestation or later requiring oxygen or ventilation in the delivery room and subsequent NICU admission for respiratory support. Therefore, we conducted a secondary analysis after limiting to pregnancies !34 weeks of gestation. We examined NICU respiratory support and respiratory morbidity. NICU respiratory support included oxygen by nasal cannula, oxygen by isolette/blow-by, continuous positive airway pressure (CPAP)/bilevel positive airway pressure (BiPAP)/noninvasive positive pressure, mechanical ventilator, oscillator, and surfactant administration. Respiratory morbidity included RDS/HMD (hyaline membrane disease), radiography-verified RDS/HMD, TTN, pneumonia (radiography-verified cases), apnea and bradycardia, pulmonary hypertension, pneumothorax, meconium aspiration, pulmonary hypoplasia, and respiratory failure. These were compared within non-DM, GDM, and pregestational DM after stratifying by probability of delivery at term. Due to repeated pregnancies in the data, linear and ordinal logistic regressions with generalized estimating equation (GEE) were used to compare maternal characteristics and neonatal outcomes so that gestational diabetes and pregestational diabetes were compared with the non-DM group separately. Multivariable logistic regression analysis was performed to calculate the probability of delivery at term. Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated for respiratory morbidity associated with GDM or pregestational DM compared with women without DM (referent group), controlling for maternal age, BMI at delivery, race/ethnicity, insurance, parity, marital status, smoking, precursor for delivery (spontaneous labor, premature rupture of membranes, indicated, elective, and no recorded information), and hospital type as fixed effects. All statistical analyses were performed using SAS 9.4 (SAS Institute Inc., Cary, NC).
Results
Pregnancy characteristics are presented in ►Table 1. There were 11,327 (5.1%) women with GDM and 3,296 (1.5%) women with pregestational DM. Pregnancy characteristics were different significantly among groups. Women with GDM and pregestational DM compared with women without DM were older, more obese, non-Hispanic black (pregestational DM only) or Hispanic, multiparous; more likely to have chronic hypertension, pregnancy-associated hypertension, and cesarean delivery; and more likely to deliver infants with birth weight >4,000 g or <2,500 g and at earlier gestation (all p < 0.01). Women with pregestational DM compared with women with GDM and without DM were more likely to be not married, and to have public insurance (p < 0.01). The rate of antenatal corticosteroid administration was higher in women with pregestational DM compared with women with GDM and without DM (p < 0.01). However, there was no statistical difference in the rate of antenatal corticosteroids among women who delivered at <34 weeks of gestation (p ¼ 0.12). Neonatal respiratory morbidity is presented in ►Table 2. Women with GDM and pregestational DM compared with women without DM had higher levels of delivery room resuscitation, RDS, TTN, apnea/bradycardia, mechanical ventilation, and NICU admission (all p < 0.01). Women with pregestational DM compared with women with GDM and without DM were more likely to have pneumonia, stillbirth, neonatal death, and perinatal mortality (all p < 0.01 except pneumonia [p ¼ 0.01]).
Neonatal respiratory morbidity stratified by the probability to deliver at term is presented in ►Table 3. GDM and pregestational DM were associated with increased risks of neonatal respiratory morbidity compared with women without diabetes regardless of the probability to deliver at term, although the risks tended to be higher with a higher probability to deliver at term. These findings indicate that the neonatal respiratory morbidity associated with diabetes was not fully explained by greater propensity of prematurity. In addition, neonatal respiratory morbidities were increased with pregestational DM compared with GDM.
Information on neonatal respiratory support and morbidity from the detailed NICU chart reviews for deliveries at 34 weeks or greater are presented in ►Table 4. The results were similar in that GDM and pregestational DM were associated with higher levels of neonatal respiratory support and risk of neonatal respiratory morbidity compared with women without diabetes in pregnancy, and the risks were higher for pregestational DM compared with GDM. Due to the small numbers, many of the adjusted ORs of neonatal respiratory support and respiratory morbidity were unable to be calculated (►Table 5). However, for pregestational diabetes, CPAP/BiPAP/noninvasive positive pressure support and RDS/HMD were increased with a higher probability to deliver at term, again indicating that these morbidities were not fully explained by a greater propensity of prematurity.
Comment
In this large, multi-institutional cohort of women, the risk of neonatal respiratory morbidity was higher for women with GDM or pregestational DM compared with women without diabetes in pregnancy, and these risks were increased beyond what can be attributed to prematurity. In addition, neonatal respiratory morbidity appeared higher in women with pregestational DM compared with GDM.
Previous studies have suggested that GDM and pregestational DM are associated with an increased risk of neonatal respiratory morbidity.
4-8 However, it was unclear whether the respiratory morbidity was due to diabetes versus the physiologic immaturity associated with earlier delivery. Stratifying by actual gestational age at delivery can be confounded by the indication for delivery, as more complicated pregnancies might be delivered earlier, and the underlying reason for delivery itself can be associated with an increased risk of neonatal respiratory morbidity. Our analysis using propensity scores analyzed the association of GDM and pregestational DM with neonatal respiratory morbidity in pregnancies with otherwise similar baseline characteristics (either high or low probability to deliver at term). 18 In our study, stronger associations between diabetes and neonatal respiratory morbidity were found in women with a high probability to deliver at term. These findings indicate that the neonatal respiratory morbidity associated with diabetes was not fully explained by the physiologic immaturity associated with prematurity and support the concept that diabetes itself is a risk factor. However, the cause of increased risks of neonatal respiratory morbidity associated with diabetes is unclear. Fetal hyperglycemia and hyperinsulinemia have been suggested mechanisms of increased neonatal respiratory morbidity. 9 In a study of fetal lung tissue, insulin has been found to decrease the expression of surfactant protein A (SP-A) and SP-B. 20,21 A previous study found poor glycemic control (defined by mean blood glucose >105 mg/dL) was associated with delayed appearance of phosphatidylglycerol in pregestational DM, which may suggest maternal hyperglycemia is associated with neonatal respiratory morbidity. 22 Increased risk of cesarean delivery 4, 6 in women with GDM and pregestational DM may also be contributing the increased risk of neonatal respiratory morbidity.
11,12
Data regarding neonatal respiratory morbidity comparing GDM and pregestational DM have been limited and conflicting. and 73 pregestational DM at all gestational age) found that pregestational DM was associated with increased risk of neonatal respiratory morbidity compared with GDM. 13 Conflicting results may be due to small sample size, and heterogeneous groups (singletons and multiple pregnancies, 4 term and preterm 5, 13 ). Our study demonstrated higher neonatal respiratory morbidity associated with pregestational DM compared with GDM. The cause of higher risk is unclear, but we postulate that hyperglycemia at earlier gestational age and increased risks of other morbidities such as hypertensive disease, renal disease, and infection 23 may be associated with increased risk of neonatal respiratory morbidity in women with pregestational DM. Considering the propensity of preterm delivery helped determine the risk of neonatal respiratory morbidity associated with GDM and pregestational DM compared with non-DM beyond what can be attributed to prematurity. Limitations of this study should be noted. Our study did not have information on treatment of GDM and pregestational diabetes. However, we think our findings are still clinically relevant because they are somewhat representative of the population risk of neonatal respiratory disease with general management of a large number of women from multiple institutions across the United States. Although mapping data of key variables from electronic medical records was highly concordant with chart review, data on GDM and pregestational DM were not explicitly validated. Although we controlled for several covariates, we cannot exclude the possibility of impact from residual confounding. Also despite the large sample size compared with previous studies, 4-8 our study may be underpowered to analyze uncommon outcomes. The major strength of this study is the large cohort with detailed neonatal outcomes and chart review on a subset of neonates, enabling us to provide the most conclusive evidence to date that respiratory morbidity was higher in pregnancies complicated by pregestational DM compared with GDM. Note: Significant findings are bolded. Some analyses had too few observations to calculate aORs. The rates of these outcomes are presented in ►Table 5.
a Multivariable logistic regression analysis using generalized estimating equations to account for correlated data was performed to calculate the probability of delivery at term. ORs with 95% CIs were calculated for respiratory morbidity associated with GDM or pregestational DM compared with women without DM (referent group) controlling for maternal age, BMI at delivery, race, insurance, parity, marital status, smoking, precursor for delivery (spontaneous labor, premature rupture of membranes, indicated, elective, and no recorded information) and hospital site.
We found increased risk of neonatal respiratory morbidity in women with GDM and pregestational DM compared with women without DM. Neonatal respiratory morbidity was especially higher in women with pregestational DM. The optimal timing of delivery in women with GDM and pregestational DM whose serum glucose is poorly controlled is unclear. 24, 25 As infants of women with GDM and pregestational DM are especially vulnerable to neonatal respiratory morbidity, the timing of delivery should be carefully considered.
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